Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NasdaqGS
6.01 Up 0.06(0.92%) 4:00PM EDT
|After Hours : 5.95 Down 0.06 (0.92%) 6:09PM EDT
Add to Portfolio
Prev Close:5.95
Open:5.93
Bid:5.75 x 2000
Ask:6.36 x 1000
1y Target Est:9.50
Beta:0.85
Earnings Date:May 4 - May 8 (Est.)
Day's Range:5.88 - 6.05
52wk Range:5.65 - 9.27
Volume:708,045
Avg Vol (3m):1,248,600
Market Cap:391.20M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SPPIUp 0.92%391.20M
BIIBUp 0.22%100.85B
RHHBYDown 0.23%N/A
TEVADown 0.70%52.80B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.07
Ex-Dividend Date:18-Dec-12

Analysts

Annual EPS Est (Dec-15) :-0.70
Quarterly EPS Est (Mar-15) :-0.06
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback